Page 1433 - Small Animal Internal Medicine, 6th Edition
P. 1433

CHAPTER 87   Disorders of Hemostasis   1405


            THROMBOSIS                                           sighthounds. Decreased activity of the natural anticoagulant
                                                                 AT plays a major role in the thrombosis seen in dogs with
  VetBooks.ir  Thrombotic and thromboembolic disorders appear to be   protein-losing nephropathy or protein-losing enteropathy;
                                                                 in  addition,  humans  with  hypertension  frequently  have  a
            considerably less common in cats and dogs than in humans.
            Several situations can result in thrombosis or TE, including
            stasis of blood, activation of intravascular coagulation in an   high concentration of PAI-1, which in turn inhibits fibrino-
                                                                 lysis, thus resulting in a net procoagulant effect. This mecha-
            area of abnormal or damaged endothelium, decreased activ-  nism may also be important in dogs with protein-losing
            ity of natural anticoagulants, and decreased or impaired   nephropathy and hypertension. The decreased AT activity
            fibrinolysis.  Thrombosis  has been recognized clinically  as   stems from the fact that this is a relatively small molecule
            associated  with  cardiomyopathy,  hyperadrenocorticism,   (≈60 kDa) that is easily lost in the urine or gut contents in
            protein-losing  enteropathy  and  nephropathy,  and  IHA.  A   dogs  with  either  of these two  disorders.  The  thrombosis
            syndrome of aortoiliac thrombosis has been recognized pri-  commonly seen in dogs with hyperadrenocorticism is likely
            marily in Cavalier King Charles Spaniels, Greyhounds, and   related to the induction of PAI-1 synthesis by corticosteroids
            other sighthound breeds (Goncalves et al., 2008;  Lake-  (corticosteroids inhibit fibrinolysis). An increased risk for
            Bakaar et al., 2012).                                TE  has  been  recognized  in  dogs  with  IHA.  Although  the
              Diagnosing TE is not an easy task. Clinical signs are vari-  pathogenesis of these disorders is obscure, the release of
            able and include signs associated with parenchymal organ   procoagulants from the lysed RBCs has been postulated as a
            ischemia (e.g., dyspnea from pulmonary TE, high liver   cause; sludging of autoagglutinated RBCs in the microcircu-
            enzyme activities in patients with hepatic TE, intermittent   lation is also likely to contribute to this procoagulant state.
            rear limb claudication in dogs with aortic thrombosis). A   Dogs and cats at high risk for thrombosis or TE should
            positive D-dimer test has been reported to be associated with   receive anticoagulants. The two drugs commonly used in
            TE disease in dogs, but that is not my experience. TEG is a   cats and dogs at risk for this condition are aspirin and
            rapid and sensitive test to diagnose TE disease in some dogs   heparin. Coumarin derivatives are commonly used in
            (Fig. 87.5); however, in a large proportion of dogs with overt   humans, but in dogs and cats they can result in excessive
            thrombosis, the TEG tracings are normal.             bleeding. In  recent reports  of human AT  deficiency, ana-
              Stasis of blood and possibly an irregular endothelial   bolic steroids such as stanozolol have also been suggested
            surface appear to be the major causes in cats with aortic   to decrease the risk of thrombotic disorders because of their
            (iliac) TE secondary to hypertrophic cardiomyopathy. Arte-  stimulatory effect on the fibrinolytic system. The recogni-
            rial pathology and high blood viscosity associated with a   tion and management of pulmonary TE are discussed in
            high  hematocrit  are  suspected  in  Greyhounds  and  other   Chapter 22.
















                                     A













                                     B
                          FIG 87.5
                          (A) Thromboelastograph Hemostasis Analyzer system (TEG) tracing in a normal dog. The
                          maximum amplitude (MA) provides information on the strength of the clot and is within the
                          reference range (53.9 mm). (B) TEG tracing in a dog with hypercoagulability. Note that
                          the MA is 80.3 mm.
   1428   1429   1430   1431   1432   1433   1434   1435   1436   1437   1438